Northwell Health Makes Strategic Move Into Wearable Technology

Northwell Health today announced a new partnership agreement with Peerbridge Health Inc. to pioneer the future of remote medical monitoring. Peerbridge technology enables remote patient monitoring through multiple on-body wireless sensors conveying powerful intelligence effortlessly.

Northwell Health Makes Strategic Move into Wearable Technology

Signs strategic partnership with Peerbridge Health, Inc.

NEW YORK — Northwell Health entered a new partnership agreement with Peerbridge Health Inc., to pioneer the future of remote medical monitoring. Peerbridge’s technology enables remote patient monitoring through multiple on-body wireless sensors conveying powerful intelligence effortlessly.

The move further solidifies Northwell’s commitment to improving the patient experience and the health of the communities it serves throughout the New York metropolitan area, and reducing operational cost.

“Our collaboration with Peerbridge Health is part of our overarching strategy to introduce disruptive technologies that will help shape the future of health care delivery,” said Michael Dowling, president and CEO of Northwell Health.

To better understand the potential of this partnership, Peerbridge Health and Northwell conducted a clinical trial to measure the performance of the company’s flagship product, the Peerbridge CorTM, a compact, lightweight, multi-channel electrocardiogram monitor. To ensure efficacy, the Peerbridge Cor was compared to other cardiovascular monitors in a clinical trial.

“The trial demonstrated this technology was superior to the current Holter Monitor standard,” said Nicholas Skipitaris, MD, chief of electrophysiology at Lenox Hill Hospital. “Not only did the Peerbridge Cor deliver excellent, multi-channel, analyzable data, but it delivered less motion artifact and fewer false positives, despite our patient’s active New York lifestyle.”

“Our vision is to help consumers partner with their physicians through easily accessible remote monitoring options,” said Arthur Bertolero, Chief Business Officer of Peerbridge Health. “Northwell has been a strong strategic partner, sharing our passion to bring effective digital solutions to consumers and health professionals with the highest medical standard.”

Incidence/Cost of Cardiovascular

The American Heart Association reports cardiovascular disease and stroke as the top two killers of American adults. Cardiovascular monitoring, both inside and outside medical environments, is critical for diagnosis, proper treatment, and improved outcomes.

According to the US Center for Disease Control & Prevention Foundation, annual direct medical costs associated with cardiovascular diseases are projected to rise to more

than $818 billion by 2030. To get ahead of the growth in patient demand, an increasing number of providers are looking for more efficient monitoring like Peerbridge to improve treatment and deliver better outcomes, which also has the potential to significantly reduce expenses.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 22 hospitals and over 550 outpatient facilities. We care for more than two million people annually in the metro New York area and beyond, thanks to philanthropic support from our communities. Our 61,000 employees – 15,000+ nurses and nearly 3,900 physicians, including about 2,800 members of Northwell Health Physician Partners — are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institute. We’re training the next generation of medical professionals at the visionary Hofstra Northwell School of Medicine and the School of Graduate Nursing and Physician Assistant Studies. And we offer health insurance through CareConnect. For information on our more than 100 medical specialties, visit

About Peerbridge Health

Headquartered in New York, NY, Peerbridge HealthTM is a digital healthcare company providing the most clear and comprehensive ECG findings. Our Peerbridge CorTM is an ambulatory ECG device that helps physicians diagnose arrhythmias more quickly and accurately, resulting in the best possible patient outcomes. Peerbridge Health also holds several pioneering patents incorporating multiple on-body sensors that communicate vital sign information via a single transmitter. To learn more about our innovative products, visit

Related Posts